ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Descemet Endothelial Thickness Comparison Trial II

ClinicalTrials.gov ID: NCT05275972

Public ClinicalTrials.gov record NCT05275972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Descemet Endothelial Thickness Comparison Trials (DETECT I & II)

Study identification

NCT ID
NCT05275972
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stanford University
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Ripasudil Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2023
Primary completion
Nov 29, 2027
Completion
Nov 29, 2028
Last update posted
May 7, 2026

2023 – 2028

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Stanford University Palo Alto California 94303 Recruiting
University of California Davis Sacramento California 95817 Recruiting
University of Miami Palm Beach Gardens Florida 33418 Recruiting
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 Recruiting
Legacy Devers Eye Institute Portland Oregon 97210 Recruiting
Oregon Health & Science University Portland Oregon 97239 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
Wills Eye Hospital Philadelphia Pennsylvania 19107 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05275972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05275972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →